Original BioMedicals Co., Ltd. engages in the development of non-new ingredients new drugs. Its products include radiation injury prevention drug with amifostine compound, amifostine combined microcellular chemotherapy adjuvant, and peptide-like compound for the treatment of microcellular diabetes. The company was founded by Chia Hung Chen on December 05, 2011 and is headquartered in Tainan, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company